BioNTech SE (BNTX) Reports Q4 EPS of EUR12.18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR12.18. Revenue for the quarter came in at EUR5.53 billion.
Estimated BioNTech COVID-19 vaccine revenues for the full 2022 financial year €13 billion - €17 billion
For earnings history and earnings-related data on BioNTech SE (BNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real Industry (RELY) Tops Q3 EPS by 15c; offers guidance
- Socket Mobile (SCKT) Reports Q3 Loss of $0.09
- Prospect Capital (PSEC) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
Corporate News, Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
